114 related articles for article (PubMed ID: 2007447)
21. The function of the corpus luteum of pregnancy in ovulatory dysfunction and luteal phase deficiency.
Soules MR; Hughes CL; Aksel S; Tyrey L; Hammond CB
Fertil Steril; 1981 Jul; 36(1):31-6. PubMed ID: 7250405
[TBL] [Abstract][Full Text] [Related]
22. [Potentiation of ovarian response to H.C.G. with Clomiphene. Application to the treatment of luteal deficiency].
Geller S; Scholler R
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5):417-34. PubMed ID: 4640959
[No Abstract] [Full Text] [Related]
23. Single luteal phase serum progesterone assay as an indicator of ovulation.
Israel R; Mishell DR; Stone SC; Thorneycroft IH; Moyer DL
Am J Obstet Gynecol; 1972 Apr; 112(8):1043-6. PubMed ID: 5017634
[TBL] [Abstract][Full Text] [Related]
24. Use of urinary pregnanediol 3-glucuronide to confirm ovulation.
Ecochard R; Leiva R; Bouchard T; Boehringer H; Direito A; Mariani A; Fehring R
Steroids; 2013 Oct; 78(10):1035-40. PubMed ID: 23831784
[TBL] [Abstract][Full Text] [Related]
25. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
Branch CM; Collins PO; Kilpatrick MJ; Collins WP
Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a reference ELISA for measurement of universal thresholds of pregnanediol glucuronide excretion rates using urine samples diluted to a constant volume per unit time.
Binnie JE; Cooke DG; Blackwell LF
J Immunoassay Immunochem; 2017; 38(2):202-220. PubMed ID: 27636357
[TBL] [Abstract][Full Text] [Related]
27. [Functional insufficiency of corpus luteum].
Cohen J
Contracept Fertil Sex (Paris); 1976; 4(3):193-5, 198-202. PubMed ID: 1261730
[No Abstract] [Full Text] [Related]
28. [Functional characteristics of the corpus luteum].
Ovsiannikova TV; Pshenichnikova TI
Akush Ginekol (Mosk); 1981 Jul; (7):3-5. PubMed ID: 6272589
[No Abstract] [Full Text] [Related]
29. Confirmation of ovulation from urinary progesterone analysis: assessment of two automated assay platforms.
Gifford RM; Howie F; Wilson K; Johnston N; Todisco T; Crane M; Greeves JP; Skorupskaite K; Woods DR; Reynolds RM; Anderson RA
Sci Rep; 2018 Dec; 8(1):17621. PubMed ID: 30514870
[TBL] [Abstract][Full Text] [Related]
30. [Luteinization of unruptured follicles during clomiphene treatment].
Lin JF
Zhonghua Fu Chan Ke Za Zhi; 1992 Mar; 27(2):86-9, 124. PubMed ID: 1395892
[TBL] [Abstract][Full Text] [Related]
31. The luteal phase after hyperstimulation for in vitro fertilization.
Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB
Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of pregnanediol excretion in women].
Friedrich F; Kemeter P
Wien Klin Wochenschr; 1973 May; 85(20):262-5. PubMed ID: 4704832
[No Abstract] [Full Text] [Related]
33. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
34. Relationship of luteinizing hormone, pregnanediol-3-glucuronide, and estriol-16-glucuronide in urine of infertile women with endometriosis.
Cheesman KL; Ben-Nun ; Chatterton RT; Cohen MR
Fertil Steril; 1982 Nov; 38(5):542-8. PubMed ID: 7128839
[TBL] [Abstract][Full Text] [Related]
35. [Qualitative determination of U-pregnanediol-3 alpha-glucuronide in 5 minutes. A clinical trial of a new matrix cushion test].
Bødker B; Philipsen T; Bagger PV
Ugeskr Laeger; 1990 Apr; 152(18):1307-8. PubMed ID: 2188406
[TBL] [Abstract][Full Text] [Related]
36. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
37. Use of the Home Ovarian Monitor in pregnancy avoidance.
Brown JB; Holmes J; Barker G
Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
[TBL] [Abstract][Full Text] [Related]
38. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
39. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
40. Effect of clomiphene citrate administration during the early luteal phase on the luteal function and pregnancy rate of women.
Miyake A; Yoshimoto Y; Hirota K; Wakimoto H; Terakawa N; Aono T; Tanizawa O
Eur J Obstet Gynecol Reprod Biol; 1987 Sep; 26(1):19-25. PubMed ID: 3666262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
